ASH's Treating Fairly Research Award funds research on health disparities in hematology, supporting studies that investigate causes or develop interventions to advance equity for affected communities.
Funder: American Society of Hematology
Due Dates (Anticipated): January 2027 (Application deadline, projected)
Funding Amounts: $200,000 total, paid over 1–3 years depending on recipient’s preference
Summary: Supports research advancing equity in hematology, focusing on diseases and outcomes disproportionately affecting specific communities.
Key Information: No more than $500,000 in other resources allowed; ASH membership required at application and throughout award period.
The Treating Fairly Research Award, offered by the American Society of Hematology (ASH), supports research that addresses health disparities in hematologic diseases and disorders, particularly those that disproportionately impact specific communities. The award reflects ASH’s commitment to advancing fairness and equity in hematology by funding projects that investigate the causes of health outcome disparities or develop targeted interventions to reduce these gaps. Research projects may include basic, translational, clinical, or outcomes-based research and should be designed to either deepen understanding of why certain populations experience poorer health or to create interventions that improve outcomes for all hematology patients.